A Phase 3 Open-Label Clinical Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection
Read More at Micobiome.Ferring.com
Read More at Rebiotix News
Informed Consent Disclosure